BHVN News and Press, Biohaven Pharmaceutical Holding Company Ltd. From 05/29/24

Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple The...

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors PR Newswire -BHV-1510 is a novel trophoblast cell surface antigen-2 (Trop-2) directed antibody drug conjugate (ADC) that has demonstra...

2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...

2024-05-19 12:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-18 03:10:13 ET Summary Biohaven Ltd. is a spinout of Biohaven Pharmaceutical, focusing on developing drugs in the life sciences field. BHVN has three Phase 3 drug candidates: troriluzole for OCD, taldefgrobep alfa for SMA, and BHV-7000 for epilepsy and bipolar disorder. ...

2024-05-09 17:57:26 ET More on Biohaven Biohaven's Bounce Back: A Missed Call Turns Bullish (Rating Upgrade) Biohaven drops 4%, prices $230M share offering Biohaven stock slides 15% amid data presentations Seeking Alpha’s Quant Rating on Biohaven ...

Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments PR Newswire Cash, cash equivalents, marketable securities and restricted cash totaled approximately $287.6 million on March 31, 2024 , which excludes the net proceeds of approximatel...

2024-05-01 14:38:49 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks are full of intriguing innovators who could help pave the way for greater gains over the years ahead. Undoubtedly, it’s virtually impossible to tell exactly which pill...

2024-04-26 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you follow Warren Buffett’s advice of being greedy when others are fearful, then it probably makes sense to consider biotech stocks to buy on the dip. Primarily, the thesis ce...

2024-04-19 23:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...